Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Electrolyte Disturbances—Implications for Anesthetic Management
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=50915#.VFB-I1fHRK0
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=50915#.VFB-I1fHRK0
Author(s)
The administration of hyperthermic intraperitoneal
chemotherapy (HIPEC) is often associated with significant intraoperative
electrolyte changes. We retrospectively examined the pre-HIPEC and
post-HIPEC intraoperative basic metabolic panel (BMP) values of the 20
patients who underwent HIPEC at our institution between December 2009
and January 2012. For the five patients who underwent HIPEC with
oxaliplatin in 5% dextrose in water (D5W), there were statistically
significant changes between the pre- and post-HIPEC values of sodium
(135 to 124 mmol/L), chloride (105 to 94 mmol/L), glucose (143 to 388
mg/dl) and sodium corrected for hyperglycemia (135 to 127 mmol/L). For
the 14 patients who received HIPEC with mitomycin C in normal saline
(NS), there were statistically significant changes in bicarbonate (24 to
21 meQ/L), blood urea nitrogen (BUN) (10 to 9 mg/dl) and glucose (158
to 134 mg/dl). The BMP changes for the one patient who received
doxorubicin/cisplatin in peritoneal dialysate are reported separately.
KEYWORDS
Cite this paper
Raytis, J. and Lew, M. (2014) Hyperthermic
Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Electrolyte
Disturbances—Implications for Anesthetic Management. Open Journal of Anesthesiology, 4, 240-243. doi: 10.4236/ojanes.2014.410036.
| [1] |
Cashin, P.H., Graf, W., Nygren,
P. and Mahteme, H. (2012) Intraoperative Hyperthermic Versus
Postoperative Normothermic Intraperitoneal Chemotherapy for Colonic
Peritoneal Carcinomatosis: A Case-Control Study. Annals of Oncology, 3,
647-652. http://dx.doi.org/10.1093/annonc/mdr301 |
| [2] |
Elias, D., Lefevre, J.H.,
Chevalier, J., Brouquet, A., Marchal, F., Classe, J.M., et al. (2009)
Complete Cytoreductive Surgery plus Intraperitoneal Chemohyperthermia
with Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin.
Journal of Clinical Oncology, 5, 681-685. http://dx.doi.org/10.1200/JCO.2008.19.7160 |
| [3] |
Zhu, Z.G., Tang, R., Yan, M.,
Chen, J., Yang, Q.M., Li, C., et al. (2006) Efficacy and Safety of
Intraoperative Peritoneal Hyperthermic Chemotherapy for Advanced Gastric
Cancer Patients with Serosal Invasion. Digestive Surgery, 23, 93-102. http://dx.doi.org/10.1159/000093778 |
| [4] |
Schmidt, C., Creutzenberg, M.,
Piso, P., Hobbhahn, J. and Bucher, M. (2008) Perioperative Anesthetic
Management of Cytoreductive Surgery with Hyperthermic Intraperitoneal
Chemotherapy. Anaesthesia, 63, 389-395. http://dx.doi.org/10.1111/j.1365-2044.2007.05380.x |
| [5] |
Rueth, N.M., Murray, S.E.,
Huddleston, S.J., Abbott, A.M., Greeno, E.W., Kirstein, M.N., et al.
(2011) Severe Electrolyte Disturbances after Hyperthermic
Intraperitoneal Chemotherapy: Oxaliplatin Virus Mitomycin C. Annals of
Surgical Oncology, 18, 174-180. http://dx.doi.org/10.1245/s10434-010-1210-1 |
| [6] |
Song, E.C., Chu, K., Jeong,
S.W., Jung, K.H., Kim, S.H., Kim, M. and Yoon, B.W. (2003) Hyperglycemia
Exacerbates Brain Edema and Perihematomal Cell Death after
Intracerebral Hemorrhage. Stroke, 34, 2215-2220. http://dx.doi.org/10.1161/01.STR.0000088060.83709.2C eww141029lx |
| [7] | Sharma, H.S. (2006) Hyperthermia Induced Brain Oedema: Current Status and Future Prespectives. Indian Journal of Medical Research, 123, 629-652. |
评论
发表评论